

Anixa Biosciences shares new data from its ovarian cancer trial, showing patients lived longer than expected with no serious safety concerns, as regulators...
You can purchase shares of Anixa Biosciences (NASDAQ:ANIX) through any online brokerage.
Other companies in Anixa Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Anixa Biosciences has a consensus price target of $9.00.
The stock price for Anixa Biosciences (NASDAQ: ANIX) is $2.7448 last updated November 12, 2026 at 5:10 PM EST.
There are no upcoming dividends for Anixa Biosciences.
Anixa Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Anixa Biosciences.
Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer...